Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary causative agent of enzootic pneumonia (EP), one of the most economically important infectious disease for the swine industry worldwide. M. hyopneumoniae transmission occurs mainly by direct contact (nose-to-nose) between infected to susceptible pigs as well as from infected dams to their offspring (sow-to-piglet). Since disease severity has been correlated with M. hyopneumoniae prevalence at weaning in some studies, and gilts are considered the main bacterial shedders, an effective gilt acclimation program should help controlling M. hyopneumoniae in swine farms. The present review summarizes the different M. hyopneumoniae monitoring strategies of incoming gilts and recipient herd and proposes a farm classification according to their health statuses. The medication and vaccination programs against M. hyopneumoniae most used in replacement gilts are reviewed as well. Gilt replacement acclimation against M. hyopneumoniae in Europe and North America indicates that vaccination is the main strategy used, but there is a current trend in US to deliberately expose gilts to the pathogen.
Introduction
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the causative agent of Mycoplasmal pneumonia (MP), an important porcine respiratory disease. This infectious process is frequently complicated by other respiratory bacteria (such as Pasteurella multocida, Actinobacillus pleuropneumoniae and others) causing a more severe chronic and economically important disease known as enzootic pneumonia (EP). In addition to bacterial complication, viral pathogens like Porcine reproductive and respiratory syndrome virus, Porcine circovirus 2 and Swine influenza virus can aggravate the disease scenario; this viral-bacteria complex is clinically referred as porcine respiratory disease complex (PRDC) (Thacker and Minion, 2012) . Despite all efforts implemented to reduce the economic impact caused by M. hyopneumoniae (vaccination and antimicrobial treatments together with improvement of management practices), EP and PRDC still cause great concern in the swine industry worldwide.
EP mainly affects growing and finishing pigs and it is characterized by dry, non-productive cough, reduction in growth rate, and increased feed conversion ratio. The severity of the disease is dependent on the presence of co-infections and environmental conditions (Maes et al., 1996) and on the virulence and number of M. hyopneumoniae strains involved (Vicca et al., 2003; Woolley et al., 2012; Michiels et al., 2017) . M. hyopneumoniae is mostly transmitted by direct contact (nose-to-nose) between pigs, horizontally from infected to susceptible/naïve pigs (Morris et al., 1995) as well as from dam to their offspring Nathues et al., 2014; Pieters et al., 2014) . Other putative indirect transmission routes are aerosol and fomites. Whereas the aerosol transmission has been experimentally proved (Fano et al., 2005; Otake et al., 2010) , transmission by fomites has not been clearly demonstrated and it can be potentially prevented by basic biosecurity practices (Batista et al., 2004; Pitkin et al., 2011) .
Different studies showed that disease severity in growing pigs is correlated with M. hyopneumoniae prevalence of piglet colonization at weaning (Fano et al., 2007; Sibila et al., 2008) . However, other studies could not show this association (Vranckx et al., 2012b) . This prevalence can be influenced by different factors such as housing and management conditions of the production system as well as dam parity, piglet's age at weaning and replacement rate (Nathues et al., 2013 (Nathues et al., , 2014 . Since newborn piglets are M. hyopneumoniae free, the most logical source of infection is the dam at the time of farrowing or during the lactation period (Sibila et al., 2007) . Some authors suggested this transmission could be influenced by the dam's parity (Calsamiglia and Pijoan, 2000; Fano et al., 2006) . Indeed, bacterial shedding of gilts or young sows seems to be higher than that of older parity sows (Boonsoongnern et al., 2012) . Therefore, the first farrowing is considered a critical moment at which M. hyopneumoniae excretion should have ceased . These latter data together with a low transmission rate (reproduction ratio [R n ] varies among 1.16-1.28 and 0.56-0.71 under experimental and field conditions, respectively) (Meyns et al., 2006; Villarreal et al., 2009; Roos et al., 2016) and the persistence of infection in pigs (up to 214 days post infection, dpi) (Pieters et al., 2009 ) imply the need of performing an effective gilt acclimation process. This effective acclimatization protocol would reduce M. hyopneumoniae shedding at first farrowing and, consequently, would decrease pre-weaning prevalence, subsequent spread of the pathogen to growing pigs, and putative respiratory problems in fattening animals (Fano et al., 2007; Sibila et al., 2008) . Therefore, assuming that gilt population are crucial in the spread of the infection, the purpose of this review was to summarize different management practices, antimicrobial treatments and vaccination protocols in replacement gilts to control M. hyopneumoniae infections in pig herds.
M. hyopneumoniae health status

Monitoring and diagnosis
One of the main risks for M. hyopneumoniae colonization in piglets at weaning is a high gilt replacement rate (Nathues et al., 2013) . Therefore, the first step to perform an appropriate adaptation of future replacements to M. hyopneumoniae is monitoring the health status of the recipient breeding herd, as well as incoming gilts to detect potential disease/infection indicators. In case of M. hyopneumoniae infection suspicion, a definitive diagnosis should be performed.
Monitoring of M. hyopneumoniae associated disease is sometimes challenging as the infection can take a clinical or subclinical course (Table 1) . In clinical cases, the observation of signs (dry, non-productive coughing) and lung lesions (pulmonary craneo-ventral consolidation) are indicative, but not exclusive of M. hyopneumoniae. In subclinical infections, animals can display M. hyopneumoniae-like lung lesions without any evidence of coughing (Maes et al., 1996) . Therefore, clinical diagnosis should be confirmed by additional laboratory tests ( Table 1) .
The most commonly used herd monitoring method is M. hyopneumoniae antibody detection by ELISA. It provides evidence of exposure to M. hyopneumoniae without differentiating maternally derived antibodies, or antibodies elicited by infection, and/or vaccination (Bandrick et al., 2011; Thacker and Minion, 2012) . Moreover, absence of antibodies (seronegative animals) may not be equivalent to a M. hyopneumoniae free status in early infection scenarios, suggesting that antibody and pathogen detection combined is the main goal for M. hyopneumoniae final diagnosis.
Different laboratory techniques have been described to confirm the presence of M. hyopneumoniae (Table 1) . The most useful technique to detect M. hyopneumoniae is polymerase chain reaction (PCR), as it can be performed using different respiratory tract samples. Up to now, there is no consensus on which type of sample from the porcine respiratory tract is the most suitable to detect bacterial DNA in live pigs. To confirm M. hyopneumoniae free status of live animals or to determine the involvement of such pathogen in an outbreak, the desired sample should be collected from the lower respiratory tract (i.e. laryngeal or tracheobronchial swabs or tracheo-bronchial lavage fluids), where M. hyopneumoniae colonization of respiratory cilia occurs (Fablet et al., 2010; Pieters et al., 2017) . In dead animals, the sample of preference is lung tissue or bronchial swab.
Recipient herd and incoming replacement classification regarding M. hyopneumoniae health status
Once the M. hyopneumoniae health status of the recipient herds and the incoming gilts has been assessed, farms and incoming replacement could be classified into negative, provisional negative and positive according the following criteria (summarized in Table 2 ):
Negative herds/replacement
Clinical signs and lung lesions associated with M. hyopneumoniae are not present and serology and detection of pathogen in lung by PCR are negative. This type of breeding and fattening farms is the less frequent one in the current swine production in Europe (Garza-Moreno et al., 2017) . Nevertheless, M. hyopneumoniae negative farms are increasingly common among gilt producers, genetic companies, high health farms and in certain countries such as United States (US), where a trend for M. hyopneumoniae elimination is growing (Maria Pieters, personal communication).
Provisional negative herds/replacement
M. hyopneumoniae-like clinical signs and lung lesions are not observed but animals are seropositive and PCR negative. The presence of antibodies against M. hyopneumoniae provides evidence of exposure to the pathogen by prior infections and/or vaccination against it. This type of farms (PCR negative and seropositive) is frequently found in US since they are applying vaccination against M. hyopneumoniae (Maria Pieters, personal communication).
Positive herds/replacement
These farms can be classified into subclinical infected or clinical affected. Subclinical infected farms can be differentiated in two different categories (I and II) according to the presence of ELISA antibodies against M. hyopneumoniae, the detection of the pathogen by PCR and the presence of lung lesions attributed to M. hyopneumoniae (Table 2) . In category I, lung lesions associated to M. hyopneumoniae are not observed, the detection of antibodies depends on the disease phase (in early stages might not be detected) but the presence of the pathogen is confirmed. Animals from herds included in category II do not show clinical signs compatible with M. hyopneumoniae but have M. hyopneumoniae-like lung lesions, antibodies against the pathogen might be detected and the presence of M. hyopneumoniae is confirmed by PCR. Finally, in clinical affected farms, infected pigs also display signs and lung lesions associated to M. hyopneumoniae.
Prevention and control
Vaccination
Vaccination against M. hyopneumoniae is the most commonly used strategy to control its associated diseases in worldwide swine production systems . Most commercial vaccines against M. hyopneumoniae are inactivated whole-cell preparations or bacterins, combined with an adjuvant to induce a stronger immune response . Administration route of these commercial vaccines is mainly intramuscular and the volume per dose can vary according to the vaccine used (Table 3) . Besides bacterins, attenuated vaccines against M. hyopneumoniae are also available in Mexico and China (Feng et al., 2013 ).
An alternative to commercial vaccines may be autogenous vaccines, based on isolated strains from the affected farm. These vaccines are not frequently used because of the difficulty to isolate M. hyopneumoniae strains and the apparent lack of vaccine safety and efficacy data. Although information is limited, a single study has compared the efficacy of immunization with homologous and heterologous strains Veterinary Microbiology 219 (2018) 23-29 against an experimental infection and no significant differences in protection were observed (Villarreal et al., 2012) . Further investigation on new vaccines, as recombinant subunit or attenuated vaccines, is required to provide an effective and total protection against M. hyopneumoniae (Simionatto et al., 2013) . Different vaccination schedules against M. hyopneumoniae have been implemented depending on the type of herd, production system, infection dynamics, and number of doses administered . Commercial vaccines are most frequently applied to piglets, prior to or after weaning (Alarcon et al., 2014) . Additionally, previous studies have shown that the weaning process does not significantly affect vaccination efficacy (Arsenakis et al., 2016) , although numerical differences in terms of performance among vaccinated and non-vaccinated groups were detected . Piglet vaccination efficacy has been widely demonstrated by reduction of clinical signs and prevalence and severity of lung lesions, improvement of production parameters, decrease of treatment costs and, in some cases, lower mortality rates (Maes et al., 1996) . Although vaccination against M. hyopneumoniae does not prevent infection (Pieters et al., 2010; Villarreal et al., 2011 Villarreal et al., , 2012 , it is able to reduce the number of microorganisms in the swine respiratory tract (Vranckx et al., 2012a; Woolley et al., 2012) .
Sow vaccination is less frequently applied, but gaining relevance every day (Bargen, 2004) . Nevertheless, a limited number of vaccines are currently licensed for the reproductive population (Table 3 ) and studies on their effect are scarce (Table 4) . Dam vaccination sought to decrease the infectious pressure, lowering bacterial load and, consequently, transmission from sow to piglet (Vranckx et al., 2012b; Takeuti et al., 2017) , as well as conferring maternal immunity via colostrum (Bandrick et al., 2011) . Indeed, some studies have shown that sow vaccination prior to farrowing is able to reduce dam-to-piglet transmission, the number of positive piglets from vaccinated sows (Ruiz et al., 2003) , and the EP lung lesions of them at abattoir . (2000) Breeding herd 2 1 w prior the antimicrobial treatment and 2 w later Breeding herd includes sows and boars; w: weeks; d: days; IU: isolation units.
Gilt vaccination combined with optimal management strategies have also been suggested to stimulate the immune response against a controlled exposure to M. hyopneumoniae (Holst et al., 2015) or in endemically infected herds (Maes et al., 2008) . Additionally, gilt vaccination is recommended to homogenize immunity of the replacement batch and avoid destabilization of recipient breeding herd (Bargen, 2004) . This is especially important when replacement is external and originates from M. hyopneumoniae negative farms. In this situation, the introduction of negative replacement stock into positive farms may contribute to the development of subpopulations of non-infected pigs, increasing the risk of pathogen re-circulation and its persistence in the farm (Takeuti et al., 2017) .
The number of required vaccine doses, application timing and its benefits are not standardized for sows and gilts. Nowadays, single vaccination is more frequently used due to the ease of implementation in farm management practices. Nevertheless, multiple-dose vaccination against M. hyopneumoniae could elicit a booster effect of the consecutive vaccine doses. The potential benefits of applying multiple vaccine doses in terms of reduction of shedding have not been yet investigated.
Medication
Since protection against M. hyopneumoniae infection and associated diseases conferred by commercial vaccines is not complete, antimicrobial treatments are frequently required in commercial swine farms to control disease outcome.
Mycoplasmas lack a cell wall, thus M. hyopneumoniae is resistant to β-lactam antibiotics. Nevertheless, several antibiotic classes are effective in reducing the incidence and severity of M. hyopneumoniae compatible lung lesions. Most commonly used antibiotics are macrolides, lincosamides, tetracycline, and fluoroquinolones, among others (Thacker and Minion, 2012) . The route of administration can be parenteral or mixed in feed / water depending on antibiotic choice.
Medication is currently used with different purposes. Parenteral medication is used to treat animals suffering from severe clinical signs, normally associated with EP and PRDC. Under field conditions medication is also commonly used to control M. hyopneumoniae infection by means of minimizing pathogen transmission. Medication of sows prior to farrowing could be utilized as an attempt to decrease the bacterial shedding to the offspring (Thacker and Minion, 2012; Holst et al., 2015) . Nevertheless, it has been shown that antibacterial treatments do not eliminate the bacterium from the host, and shedding of M. hyopneumoniae can be detected in pigs after medication programs (Overesch and Kuhnert, 2017) . Therefore, the use of antimicrobials should be limited and only justified in specific situations to avoid the development of antimicrobial resistance (Lee et al., 2013) .
Acclimation scenarios in Europe and North America
Different acclimation scenarios may be in place and should be managed according to health status of the recipient herds, as well as the replacement batch (Table 5 ). In addition, the different production systems, management practices, and acclimation strategies used could have an impact on the acclimation process performed. To understand these differences, available information about gilt acclimation strategies used in Europe and North America are detailed (Table 6 ). Garza-Moreno et al. (2017) identified the current acclimation strategies used in this continent. In this investigation, information was collected by 321 questionnaires voluntarily responded by 108 veterinarians from 18 countries. The questionnaires were focused on the assessment of M. hyopneumoniae herd status, replacement health status, acclimation strategies and methods utilized to determine its effect.
This study showed that the most common replacement origin used in Europe was external and that most respondents knew M. hyopneumoniae health status of replacement on arrival, being in most of the cases seropositive. Nevertheless, only 28% of respondents verified this theoretical M. hyopneumoniae status, being ELISA, the most used technique (Garza-Moreno et al., 2017) .
Replacement acclimation against M. hyopneumoniae was performed in most participating European farms. Although most farms have isolation units where to specifically acclimate replacement stock, several farms did not have those facilities or respondents did not answer the question. Independently of these sites, the most used strategy to acclimate gilt was vaccination alone (58%), being the number of doses most frequently administered at acclimation one and two doses. Other acclimation strategy used in Europe was the combination of vaccination together with natural exposure to potentially infected animals. However, an effective exposure to M. hyopneumoniae is difficult to reach into a natural infection scenario. Finally, among respondents who performed the acclimation on gilts, only around 25% of them verified the effect of the process, being the combination of ELISA and PCR tests the most used strategy.
North American scenario
The importance of proper gilt acclimation to the incoming breeding herd against M. hyopneumoniae is paramount and highly recognized in the North American swine industry. This importance can be evidenced in the assessment of M. hyopneumoniae health status of the replacement and the existence of facilities for acclimatization against herd pathogens (gilt development units; GDUs). GDUs are utilized to allow ample time to incoming gilt to gradually adopt the health status of the recipient herd. According to previous studies based on questionnaires collected in US (Fano and Payne, 2015) and Mexico (Centeno et al., 2016) , these acclimation facilities are in most of the cases continuous flow (72% and 75%, respectively) allowing an effective gilt exposure to M. hyopneumoniae.
Gilt vaccination in North American swine industry was also recognized as the most common practice used at acclimation (Fano and Payne, 2015; Centeno et al., 2016) . Other methods as natural exposure to M. hyopneumoniae, alone or combined with vaccination, and contact with infected cull sows or/and piglets are also used to acclimate the gilts (Dalquist, 2014; Fano and Payne, 2015) . Taking into account that pig-to-pig transmission of this bacterium has proven to be extremely slow (Meyns et al., 2004; Roos et al., 2016) , the ratio of infected and naïve gilts as well as the time of exposure are crucial and should be considered to achieve an effective exposure. Recently, early controlled exposure has been attempted to expose the gilts by administering (intratracheally) lung tissue homogenate containing M. hyopneumoniae (Fano and Payne, 2015; Centeno et al., 2016) to individual gilts or groups of them (via aerosol), since the success of exposure is higher when these controlled procedures are used (Sponheim, 2017) . Finally, according to aforementioned studies, overall, the verification of gilt acclimation process is minimally performed in North American farms.
Conclusion
M. hyopneumoniae is a respiratory pathogen that causes important economic losses to the swine industry worldwide. A proper gilt acclimation against M. hyopneumoniae prior entrance into a recipient breeding farm could maintain the farm health stability and control respiratory disease caused by this pathogen. Gilt replacement acclimation procedures against M. hyopneumoniae in Europe and North America showed that vaccination is the main strategy used, but there is a current trend in the US to deliberately expose gilts to the pathogen. Further investigations are needed to identify the ideal gilt acclimation protocol taking into account that these strategies must be based on incoming and recipient herd health statuses and the characteristics of each farm.
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